Tasmanian Devil

A Marsupial Carnivore Fighting a Contagious Cancer

The Tasmanian devil is the world's largest surviving carnivorous marsupial, found only on the Australian island of Tasmania. It is the subject of one of the most unusual conservation crises in biology: since the mid-1990s the species has been ravaged by Devil Facial Tumour Disease (DFTD) — one of only a handful of known transmissible cancers, a cancer that spreads between individuals as an infectious cell line passed through biting [Pearse & Swift 2006]. DFTD caused population declines exceeding 80% across affected areas and drove the IUCN to list Sarcophilus harrisii as Endangered [Hawkins et al. 2008].

The devil's story is scientifically extraordinary — a naturally-occurring transmissible cancer is a phenomenon known in only three mammals and a few bivalves — and conservationally instructive: it shows how a disease, rather than habitat loss or hunting, can become the primary extinction driver, and how insurance populations + emerging disease-resistance offer a path forward.

Biology and identification

Sarcophilus harrisii is a stocky, black-furred marsupial roughly the size of a small dog: adults reach 50–65 cm in body length plus a 25 cm tail, weighing 6–14 kg (males larger) [Owen & Pemberton 2005]. Most individuals have a white chest blaze and/or rump markings. The species has one of the most powerful bite forces relative to body size of any living mammal — an adaptation to its scavenging diet, in which it consumes entire carcasses including bone.

Devils are primarily nocturnal scavengers, playing a keystone ecosystem role in Tasmania by consuming carrion (which suppresses blowfly populations and removes carcasses that could otherwise spread disease) and by suppressing feral cats and foxes through competition. The loss of devils to DFTD has measurable cascading effects on Tasmanian ecosystems.

The species' courtship and feeding involve frequent biting around the face — which is precisely the transmission route for DFTD. The cancer is passed when an infected devil bites another, transferring living cancer cells that establish as tumours on the new host's face and mouth, eventually preventing feeding and causing death typically within months.

Habitat and range

Endemic to Tasmania, Australia. The species was formerly present on mainland Australia but went extinct there approximately 3,000 years ago, likely due to competition with the dingo (which never reached Tasmania) [Owen & Pemberton 2005]. On Tasmania, devils occupy a wide range of habitats — dry sclerophyll forest, coastal scrub, agricultural land, and forest edges — across most of the island.

DFTD was first documented in northeastern Tasmania in 1996 and has since spread across most of the island. Some western and southwestern populations were reached later or remain less affected, providing important comparative populations. A captive "insurance population" and disease-free island/peninsula populations (notably Maria Island, where disease-free devils were established) provide refugia against total loss.

Conservation status

The Tasmanian devil is listed as Endangered on the IUCN Red List [Hawkins et al. 2008] and under Australia's Environment Protection and Biodiversity Conservation Act. CITES does not list the species; international trade is not a threat.

Population estimates fell from approximately 140,000 before DFTD to an estimated 20,000–25,000 across Tasmania at the low point, with declines exceeding 80% in long-affected areas [Save the Tasmanian Devil Program 2024]. Encouragingly, recent research indicates that affected populations are not going extinct as early models predicted — devils appear to be evolving resistance, the disease's transmission dynamics have shifted, and populations are stabilising at lower densities rather than collapsing to zero [Margres et al. 2018].

Threats

Devil Facial Tumour Disease (DFTD) is the dominant threat. It is a clonally-transmissible cancer — the tumour cells themselves are the infectious agent, genetically distinct from the host and originating from a single devil decades ago. A second, independently-arisen transmissible cancer (DFT2) was discovered in 2014, indicating the species may be unusually prone to this phenomenon [Pye et al. 2016]. There is no widely-deployed cure; vaccine and immunotherapy research is ongoing.

Roadkill is a significant secondary threat, particularly damaging because it disproportionately removes the large, healthy, disease-resistant adults that are most valuable to population recovery. Vehicle strikes on Tasmanian roads kill thousands of devils annually.

Reduced genetic diversity — the species had low genetic diversity even before DFTD (a consequence of its island isolation and past bottlenecks), which initially limited the immune system's ability to recognise the foreign cancer cells. Genetic-rescue and resistance-breeding considerations are part of the management strategy.

Habitat loss and competition with introduced species (feral cats; foxes have been a feared but not-established threat) add pressure, though these are secondary to DFTD.

What is being done

• Save the Tasmanian Devil Program — the Tasmanian and Australian government program coordinating the response. Components include the captive insurance population, disease monitoring, the Maria Island disease-free population, and wild-population management [Save the Tasmanian Devil Program 2024].
• Insurance population — a captive metapopulation of disease-free devils maintained across Australian zoos and wildlife parks (managed under a studbook), providing a genetic reservoir against total wild loss and a source for reintroductions.
• Maria Island and peninsula populations — disease-free populations established on offshore islands and managed peninsulas as additional refugia.
• Mainland reintroduction trials — devils reintroduced to a fenced mainland-Australia sanctuary (Barrington Tops, NSW, by Aussie Ark and partners) in 2020 — the first wild devils on mainland Australia in ~3,000 years — as both a conservation insurance measure and an ecosystem-restoration experiment.
• DFTD vaccine and immunotherapy research — multiple Australian research groups (University of Tasmania's Menzies Institute, and others) working on immunisation and treatment; some trial-released devils have received experimental immunisation.
• Roadkill mitigation — signage, speed measures, and virtual-fencing trials at devil-roadkill hotspots.

How readers can help

• Support the Save the Tasmanian Devil Program and Aussie Ark. These are the principal channels for the insurance population, disease research, and mainland reintroduction work.
• Support DFTD research at the University of Tasmania's Menzies Institute and partner institutions — the vaccine/immunotherapy work is the long-term path to a wild population that can coexist with the disease.
• For Tasmanian visitors and residents: drive carefully at dawn/dusk in devil country, slow down in signed roadkill zones, and report injured devils. Roadkill removal of healthy adults is a meaningful, preventable threat.
• Visit accredited wildlife parks. Tasmanian and mainland Australian wildlife parks that participate in the insurance-population studbook channel revenue and genetics into the recovery program. Choose accredited (Zoo and Aquarium Association) facilities.
• Support the broader Tasmanian ecosystem. The devil is a keystone scavenger and mesopredator-suppressor; its decline affects the whole island ecosystem. Organizations working on Tasmanian biodiversity and feral-cat control benefit devils indirectly.

Last verified: 2026-05-24 Conservation status: Endangered (IUCN Red List 2008 assessment); affected by transmissible cancer DFTD since 1996; populations stabilising as resistance emerges.

References

• Hawkins, C. E., McCallum, H., Mooney, N., Jones, M., & Holdsworth, M. (2008). Sarcophilus harrisii. IUCN Red List of Threatened Species. e.T40540A10331066.
• Margres, M. J., Jones, M. E., Epstein, B., et al. (2018). Large-effect loci affect survival in Tasmanian devils infected with a transmissible cancer. Molecular Ecology 27: 4189–4199.
• Owen, D., & Pemberton, D. (2005). Tasmanian Devil: A Unique and Threatened Animal. Allen & Unwin.
• Pearse, A. M., & Swift, K. (2006). Transmission of devil facial-tumour disease. Nature 439: 549.
• Pye, R. J., Pemberton, D., Tovar, C., et al. (2016). A second transmissible cancer in Tasmanian devils. PNAS 113(2): 374–379.
• Save the Tasmanian Devil Program (2024). Program annual update. Tasmanian Government Department of Natural Resources and Environment. https://nre.tas.gov.au/